...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Establishment of thrombin affinity column (TAC)-HPLC-MS/MS method for screening direct thrombin inhibitors from Radix Salviae Miltiorrhiae
【24h】

Establishment of thrombin affinity column (TAC)-HPLC-MS/MS method for screening direct thrombin inhibitors from Radix Salviae Miltiorrhiae

机译:凝血酶亲和力柱(TAC)-HPLC-MS / MS / MS方法用于筛选萨尔维亚米尔蒂氏菌的直接凝血酶抑制剂的方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to develop an affinity HPLC method for screening direct thrombin inhibitors from Traditional Chinese Medicine (TCM), thrombin was immobilized on the glutaraldehyde-modified amino silica gel and was used as thrombin stationary phase. A thrombin affinity column (TAC) was made by packing the thrombin stationary phase into a bare column (2.0 * 1.0 mm, i.d.). The direct thrombin inhibitors could be screened through this TAC column. For the purpose of improvement of the discovery efficiency, a TAC-HPLC-MS/MS system was used to screen thrombin inhibitors from Radix Salviae Miltiorrhiae (RSM), a famous traditional Chinese medicine. After optimization of all the conditions, cryptotanshinone (Cry), dihydrotanshinone I (Dih-I) and tanshinone IIA (Tan-IIA) were screened out and identified as potential active components. The anticoagulant effects of these three compounds were tested by anticoagulant experiments in vitro. Furthermore, the interaction of three compounds with thrombin was studied by molecular docking. The result shows they have the potential to be used as preventive drugs. In short, this method can be used to screen anticoagulant drugs from traditional Chinese medicine, which provides convenience for screening anticoagulant drugs.
机译:为了开发一种亲和力的HPLC方法,用于将来自中药(TCM)的直接凝血酶抑制剂筛选,凝血酶固定在戊二醛改性的氨基硅胶上并用作凝血酶固定相。通过将凝血酶固定相包装成裸柱(2.0 * 1.0mm,即)来制备凝血酶亲和柱(TAC)。可以通过该TAC柱筛选直接凝血酶抑制剂。为了提高发现效率,使用TAC-HPLC-MS / MS系统用于筛选来自萨尔维亚米尔蒂氏菌(RSM)的凝血酶抑制剂,是着名的中医。在优化所有条件下,筛选出筛选加密胰岛(Cry),Dihydrotanshinone I(DiH-I)和丹参酮IIA(Tan-IIa)并鉴定为潜在的活性组分。通过体外抗凝血实验测试这三种化合物的抗凝血效果。此外,通过分子对接研究了三种化合物与凝血酶的相互作用。结果表明它们具有用作预防性药物的可能性。简而言之,这种方法可用于筛选来自中药的抗凝血药,为筛选抗凝血药提供便利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号